000			03291nam a22003255i 4500
999			_c402521 _d402521
001			402521
003			ES-MaUEC
005			20240612090951.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230629s2023 sz | o |||| 0|eng d
020			_a9783031280467
024	7		_a10.1007/978-3-031-28046-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQP188.T54 _b2023 EB
245	0	4	_aThe Bethesda System for Reporting Thyroid Cytopathology : _bDefinitions, Criteria, and Explanatory Notes _cedited by Syed Z Ali, Paul A VanderLaan
250			_a3rd ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aOverview of Diagnostic Terminology and Reporting -- Nondiagnostic/Unsatisfactory -- Benign -- Atypia of Undetermined Significance -- Follicular Neoplasm -- Follicular Neoplasm, H{uml}urthle Cell Type -- Suspicious for Malignancy -- Papillary Thyroid Carcinoma and Variants -- Medullary Thyroid Carcinoma -- Poorly Differentiated Thyroid Carcinoma -- Undifferentiated (Anaplastic) Carcinoma and Squamous Cell Carcinoma of the Thyroid -- Metastatic Tumors, Lymphomas, and Miscellaneous Lesions -- Clinical Perspectives and Imaging Studies -- Molecular and Other Ancillary Tests.
520			_a The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided important updates and advances in the practice of thyroid cytopathology. It was inspired by new developments in the field of thyroid cytopathology since the publication of the first edition in 2010. These included revised clinical guidelines for the management of patients with thyroid nodules, the introduction of molecular testing as an adjunct to cytopathologic examination, and the reclassification of the non-invasive follicular variant of papillary thyroid carcinoma as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). This new third edition provides updates to the current reporting terminology and diagnostic criteria, including new information on ancillary molecular testing, as well as imaging findings and clinical management. This book provides a more unified approach to diagnosing and reporting thyroid FNA interpretations.It simplifies the reporting structure by settling on just one name for each of the six categories and aligning terminology with the most recent classification of thyroid tumors by the World Health Organization. Written by experts in the field, The Bethesda System for Reporting Thyroid Cytopathology, Third Edition aims to inspire advances in thyroid cytopathologic diagnosis and the betterment of patients with thyroid nodular disease. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.
988			_aSpringer_Medicine_2023
650		7	_2embne _9182475 _aTiroides _xEnfermedades
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-28046-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2024 _dz _ek _zSI